Explanation
Cardiomyopathy
doxorubicin. which
Themostwellknowncause
hemotherapy-induced cardiomyopath
member of
theanthracycunegroupofagents.Theriskofdeveopingcardiomyopathy isdose-related.Other riskfactors
includemediastinaL irradiation,aqegreaterthan70years and pre-existingcardiacdisease.Monitoring of
ejectionfraction priortoand durinqtreatmentisrecommended.
Theclinicaumanifestationsofdoxorubicincardiomyvopathy arethoseof biventricularconaestiveheartfailure
(CHF).Svmptomshavebeenreportedtooccur anvtimeuptomonthsor even yearsaffter stoppinqthedrua.
AthouahCHFhasbeen reportedtohaveahiahmortauityrate.successfuutreatmemtispossibleandshouldbe
manaqedasforCHFduetoother causes.
@1MIN ENDOCRINE
